×
About 74 results

ALLMedicine™ Small Cell Lung Cancer Staging Center

Research & Reviews  31 results

Clinical Non-Small Cell Lung Cancer Staging and Tumor Length Measurement Results From U...
https://doi.org/10.1016/j.acra.2020.04.007
Academic Radiology; Wu DY, de Hoyos A et. al.

Jun 21st, 2020 - Examine the accuracy of clinical non-small cell lung cancer staging and tumor length measurements, which are critical to prognosis and treatment planning. Compare clinical and pathological staging and lengths using 10,320 2016 National Cancer Inst...

Concordance Between Rapid On-Site Evaluation and Final Cytologic Diagnosis in Patients ...
https://doi.org/10.1093/ajcp/aqz146
American Journal of Clinical Pathology; Caupena C, Esteban L et. al.

Oct 16th, 2019 - In patients with lung cancer undergoing mediastinal staging through endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), decisions are based on rapid on-site evaluation (ROSE) findings. We aimed to analyze the concordance ...

Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell...
https://doi.org/10.1016/j.jtho.2019.03.015
Journal of Thoracic Oncology : Official Publication of Th... Kratz JR, Haro GJ et. al.

Apr 8th, 2019 - Despite adoption of molecular biomarkers in the management of NSCLC, the recently adopted eighth edition of the TNM staging system utilized only clinicopathologic characteristics and validated improvement in risk stratification of early-stage dise...

Excellence in non-small cell lung cancer staging by endobronchial-TBNA: Comparison with...
https://doi.org/10.1080/13645706.2018.1513944
Minimally Invasive Therapy & Allied Technologies : MITAT ... Ozturk A, Gullu YT

Sep 28th, 2018 - Objective: To determine the correlation and/or discrepancies between positron emission tomography (PET-CT) findings, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and surgery in the staging of non-small cell lung car...

Developing and validating a novel metabolic tumor volume risk stratification system for...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286257
European Journal of Nuclear Medicine and Molecular Imaging; Pu Y, Zhang JX et. al.

Jun 8th, 2018 - We hypothesized that whole-body metabolic tumor volume (MTVwb) could be used to supplement non-small cell lung cancer (NSCLC) staging due to its independent prognostic value. The goal of this study was to develop and validate a novel MTVwb risk st...

see more →

Guidelines  4 results

Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer Update
http://ascopubs.org/full/doi/10.1200/JCO.2017.74.6065
Nasser Hanna

Oct 19th, 2017 - Provide evidence-based recommendations updating the 2015 ASCO guideline on systemic therapy for patients with stage IV non–small-cell lung cancer (NSCLC).

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidel...
https://academic.oup.com/annonc/article/28/suppl_4/iv1/3958156
Postmus, P. E.

Jul 12th, 2017 - Lung cancer is the leading cause of cancer mortality worldwide with 1. 8 million newly diagnosed cases, or 13% of all cancers diagnosed, in 2012 [1].

ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiothe...
https://www.thegreenjournal.com/article/S0167-8140(17)30376-6/fulltext
Guckenberger, M.,et al

Jun 30th, 2017 - Stereotactic body radiotherapy (SBRT) has become the standard of care for medically inoperable patients with peripherally located, early stage non-small cell lung cancer (NSCLC), and for those refusing surgical resection. Despite the availability.

Definitive and adjuvant radiotherapy in locally advanced non-small cell lung cancer
https://www.practicalradonc.org/article/S1879-8500(15)00082-X/abstract
George Rodrigues

Jun 29th, 2015 - This guideline addresses five key questions related to appropriate use of RT in the definitive and adjuvant settings for locally advanced NSCLC. First, it looks at ideal radical RT dose fractionation for radiotherapy alone and for chemoradiation.

see more →

Clinicaltrials.gov  39 results

Clinical Non-Small Cell Lung Cancer Staging and Tumor Length Measurement Results From U...
https://doi.org/10.1016/j.acra.2020.04.007
Academic Radiology; Wu DY, de Hoyos A et. al.

Jun 21st, 2020 - Examine the accuracy of clinical non-small cell lung cancer staging and tumor length measurements, which are critical to prognosis and treatment planning. Compare clinical and pathological staging and lengths using 10,320 2016 National Cancer Inst...

Concordance Between Rapid On-Site Evaluation and Final Cytologic Diagnosis in Patients ...
https://doi.org/10.1093/ajcp/aqz146
American Journal of Clinical Pathology; Caupena C, Esteban L et. al.

Oct 16th, 2019 - In patients with lung cancer undergoing mediastinal staging through endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), decisions are based on rapid on-site evaluation (ROSE) findings. We aimed to analyze the concordance ...

Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell...
https://doi.org/10.1016/j.jtho.2019.03.015
Journal of Thoracic Oncology : Official Publication of Th... Kratz JR, Haro GJ et. al.

Apr 8th, 2019 - Despite adoption of molecular biomarkers in the management of NSCLC, the recently adopted eighth edition of the TNM staging system utilized only clinicopathologic characteristics and validated improvement in risk stratification of early-stage dise...

Excellence in non-small cell lung cancer staging by endobronchial-TBNA: Comparison with...
https://doi.org/10.1080/13645706.2018.1513944
Minimally Invasive Therapy & Allied Technologies : MITAT ... Ozturk A, Gullu YT

Sep 28th, 2018 - Objective: To determine the correlation and/or discrepancies between positron emission tomography (PET-CT) findings, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and surgery in the staging of non-small cell lung car...

Developing and validating a novel metabolic tumor volume risk stratification system for...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286257
European Journal of Nuclear Medicine and Molecular Imaging; Pu Y, Zhang JX et. al.

Jun 8th, 2018 - We hypothesized that whole-body metabolic tumor volume (MTVwb) could be used to supplement non-small cell lung cancer (NSCLC) staging due to its independent prognostic value. The goal of this study was to develop and validate a novel MTVwb risk st...

see more →